SlideShare a Scribd company logo
Biopharmaceutical Formulation
Development CM3 Implementation
and Initial Testing
The KBI Experience
Daniel Kinder
23.MARCH.2016
a customer and science-focused
contract development & manufacturing organization
Boulder, Colorado
- Microbial Process Development
- Microbial cGMP Manufacturing
- Analytical Development
Durham, North Carolina
- Cell Line Development
- Cell Culture cGMP Manufacturing
- Microbial cGMP Manufacturing
- Analytical QC, Formulation, Stability
RTP, North Carolina
- Cell Culture Process Development
- Microbial Process Development
- Analytical Development
Our Locations
Our Services
Cell Line
Development
Upstream Process
Development
API Manufacturing
Downstream Process
Development
Analytical &
Formulation
Preformulation Services
Biophysical Screening
Scout the various biophysical techniques (DSC, DLS, FTIR, CD) to determine
which are most informative about the protein’s thermal and conformational
properties
Effect of pH, buffer type, and excipients on thermal and
conformational stability
Solubility Studies
Effect of pH, buffer type, ionic strength, excipients
Surfactant Screening Studies
Effect of surfactant type and concentration on aggregate and
particle formation
DOE Accelerated Stability Studies
Effect of pH, buffer type, ionic strength, and excipients on
chemical stability utilizing statistical design of experiments (DOE)
Forced Degradation Studies
Oxidation, acid & base hydrolysis, deamidation, heat, agitation,
light, freeze/thaw
Automation Opportunities
• Meet the increasing demand for more drug candidates
with faster formulation and assessment
• Conduct larger DOE’s earlier to reduce the risk of late
stage formulation failures
• High throughput experimental design and data
management to accelerate decision making
Automated sample
preparation, processing
and analysis
Electronic experimental
design and data
management
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Peter Huefner!
1.5” Clearance!
Freeslate CM3 Biologics Formulation
Development Workstation
CM3 Deck Layout
CM3 Workstation Devices
6-Channel Pipette
• Air-displacement
disposable tips
• Variable pitch for access
to a range of vial sizes
• Multiple tip sizes enable
10-1000μL pipetting
with ~1% cv precision
Positive Displacement
Pipette
• Precise liquid handling
ideal for even viscous
samples
• Tip sizes enable 10μL-
10mL pipetting
4-Channel Solid State pH Meter
• 4-channel or single channel
mode
• 96 samples can be read in 30
minutes with ±0.1 pH accuracy
• The 3mm probes can easily
access 96 well plates
CM3 Workstation Devices
Vial/plate Moving
• Vial/Plate Gripper
moves vials, microtiter
plates and pipette tip
racks
• Robotic hand performs
capping/uncapping
and removes plate
covers
Storage Carousel
• Carousel hotel
provides storage for
up to 32 racks/plates
• Barcode enabled
Viscosity Measurement
• Measurement requires only
100μL
• Shear rate measurement to
evaluate Newtonian fluid
behavior
• Temperature control 4-40ºC
CM3 Workstation Devices
Appearance Testing with Image
Station
• 2, 4, 5, 10 and 20mL vials
• Quantitative color matching to Eur.
Pharm. BY1-BY7 standards
• Calibrated turbidity measurement 10-
1000 NTU
• Particle Counting with digital image
analysis detects sizes from 80μm
CM3 On-Board Analysis
pH
Color Analysis Viscosity
Particle Count
Turbidityuv/vis
CM3 Integrated Analysis
Formulation Experiment Master Plate
Uv/vis Plate
DLS Plate
Chromatography Plates
(SEC, CEX, RP, etc.)
IEF Plate
CGE Plate
CM3 Software Suite:
Library Studio®
• Design complex experiments with
realistic graphic display and text
recipes
• Assign sample group names and
sample ID barcodes
• Automatically design volume
gradients, scale calculations,
mathematical functions and more
CM3 Software Suite:
Automation Studio®
• Executes experimental workflows
• Controls all integrated analytical instruments
• Allows direct control over the CM3 devices
CM3 Software Suite:
Automation Studio®
• Quick review of data from individual experiments by query of date,
data type, library ID, experiment conditions, etc.
CM3 Software Suite:
PolyView®
• View all data from
each experimental
condition in one
organized
spreadsheet
• Graphical data and
images displayed as
spreadsheet
• Query data from
multiple experiments
for trend analysis and
reporting
* Images from www.Freeslate.com
*
*
Questions asked by colleagues:
• What does it do?
• How fast?
• How many?
• How reliable is the data? How do you know?
• How do I get my data?
• How much effort to use?
CM3 Analytical Verification
• Liquid Handling (LiHa) Verification
• Volumes confirmed by calibrated devices
• Specific to current application
• pH Verification
• Daily calibration/verification
• Comparison with calibrated glass electrode
• Tip-to-tip variance
• Time-dependent drift
• Viscometer verification
• Calibration with standards
• Protein or glycerol routine injections
LiHa precision/accuracy affected by:
• Tip size (be sure to use the right one)
• Syringe size (max motor/drive length)
• Dispense categories (LiHa parameters)
• Touch-off
• Aspirate/dispense heights, speeds
• Delays, air gaps, etc.
• Nature of sample (e.g. viscosity, surface tension)
• Nature of vessels (source and target)
• Order of addition (what’s already in the target vial)
LiHa Event Sequence
Computer Digital Controller Voltage
MotorGearSyringe
Valve
6’ of
Tubing
Pipet
Tip
Sample
System
Fluid
LiHa Verification - Methods
• Gravimetric
• Slow but sure
• Use good technique, correct density for temperature
• Automated weighing a plus
• Unlimited volume range
• Colorimetric
• Uv/vis or fluorescent dyes (Orange-G, Me-Orange, Eosin-Y)
• Must calibrate with a verified pipet
• Very rapid read (96-wells in 10 seconds)
• Limited to volume of uv/vis plate (~200μL)
Example LiHa Optimization
(6-Tip, Gravimetric)
1000µL ADT
Target (μL) Actual (μL) %CV %∆
225 225.6 ± 0.8 0.4 0.3
450 451.1 ± 2.0 0.44 0.2
675 677.4 ± 1.1 0.16 0.4
900 902.6 ± 3.5 0.39 0.3
Colorimetric LiHa Optimization
STEP 1: Set dispense parameters to a null value
Set these values to null
(Slope = 1, Intercept = 0)
Colorimetric LiHa Optimization
STEP 2: Dispense stock dye solution into uv/vis plate
Library Studio® Design SpectraMax® O.D. data
Manually pipet this row
Example LiHa Optimization
STEP 3: Determine abs-to-volume conversion function
Beer’s Law plot for 200μL ADT
Intercept -3.137
Slope 184.06
RSQ 1.0000
Standard Function
Target volume (μL) Average (AU) SD
45.0 0.26 0.01
90.0 0.51 0.00
135.0 0.75 0.00
180.0 1.00 0.00
Standard curve
Example LiHa Optimization
“Null” Values
200µL ADT
Target (μL) Actual (μL) %CV %∆
45 44.1 ± 0.4 0.9 2
90 87.6 ± 0.4 0.4 3
135 131.6 ± 0.7 0.5 3
180 175.4 ± 0.6 0.3 3
Example LiHa Optimization
STEP 4: Plot resulting volumes to derive LiHa curve
Optimization curve for 200μL ADT
Intercept -0.191
Slope 1.0273
LiHa Function
Colorimetric LiHa Optimization
STEP 5: Input optimized values for dispense category
Plug in Slope and Intercept
Example LiHa Optimization
Corrected Values
200µL ADT
Target (μL) Actual (μL) %CV %∆
45 44.6 ± 0.2 0.4 0.9
90 89.6 ± 0.3 0.3 0.4
135 135.0 ± 0.5 0.4 0.0
180 180.4 ± 0.9 0.5 0.2
Example LiHa Optimization
Target Actual %CV %∆ Target Actual %CV %∆ Target Actual %CV %Δ
11 10.5 2 5% 45 44.6 0.50 1% 225 225.6 0.4 0%
22 21.6 1 2% 90 89.6 0.40 0% 450 451.1 0.5 0%
33 32.9 0.8 0% 135 135.0 0.40 0% 675 677.4 0.2 0%
45 44.8 0.8 0% 180 180.4 0.50 0% 900 902.6 0.4 0%
Target Actual %CV %Δ Target Actual %CV %Δ Target Actual %CV %Δ
11 11.4 2.1 4% 22 22.1 1.9 0% 50 50.1 0.6 0%
22 21.9 2.5 0% 45 45.0 1.0 0% 100 101.4 0.3 1%
34 34.1 0.6 0% 70 70.6 0.9 1% 150 151.4 0.5 1%
45 44.6 0.5 1% 90 90.9 0.4 1% 200 199.9 0.2 0%
Target Actual %CV %Δ Target Actual %CV %Δ Target Actual %CV %Δ
225 224.5 0.3 0% 1100 1117.5 2.9 2% 2250 2215.2 0.9 2%
450 449.9 0.2 0% 2200 2230.3 1.0 1% 4500 4474.7 0.2 1%
675 673.7 0.1 0% 3300 3274.4 0.3 1% 6750 6727.9 0.3 0%
900 898.4 0.0 0% 4400 4342.2 0.3 1% 9000 9003.0 0.0 0%
1mL PDT 5mL PDT 10mL PDT
50µL ADT 200µL ADT 1000µL ADT
50µL PDT 100µL PDT 250µL PDT
What about viscous samples?
Pipet neat glycerol to prepare mixtures and measure viscosity:
%wt Glycerol Viscosity (CM3)
0.0% 0.82
18.8% 1.51
40.3% 3.52
50.5% 5.69
60.1% 9.66
64.4% 13.14
67.0% 15.83
69.8% 19.55
71.9% 23.34
74.8% 29.71
76.7% 35.79
79.8% 47.14
( Viscosity of glycerol = 1412 cP ! )
Literature Resources
• “A Simple Method for Validation and Verification of Pipettes
Mounted on Automated Liquid Handlers”, Michael Stangegaard
et al, Journal of Laboratory Automation, October, 2011, pp 381-
386.
• “Practical Considerations of Liquid Handling Devices in Drug
Discovery”, Sergio C. Chai et al, (online book)
http://dx.doi.org/10.5772/52546.
• “Improving Accuracy by Use of Technique Calibration”, Lisa
Knapp, et al, (Beckman Coulter technical bulletin)
https://www.beckmancoulter.com/wsrportal/bibliography?docnam
e=T-1915A.pdf.
Example: Buffer Prep and pH
• Biologic pharmaceuticals are typically handled in
formulations of very precise composition
• pH control is maintained by buffer systems
(phosphate, citrate, acetate, etc.)
• An in-house table of buffer recipes to achieve target
pH’s would be useful
• Great CM3 training/verification activity
Example: Buffer Prep and pH
Library Studio® Design of Buffer Prep
Example: Buffer Prep and pH
Mixtures from buffer stock solutions
Buffer
Acid
Buffer
Base
Target
pH
CM3 preparing citrate buffer mixtures
in 96-DWP
Example: Buffer Prep and pH
Plot of pH vs. Phosphate Base added
( NaH2PO4/Na2HPO4 )
Sample A (μl) B (μl) Target pH CM3 pH           Δ
1 950 0 (Neat Acid) 4.47 NA
2 870 80 5.8 5.80 0.00
3 840 110 6.0 5.94 ‐0.06
4 810 140 6.2 6.03 ‐0.17
5 700 250 6.4 6.31 ‐0.09
6 600 350 6.6 6.58 ‐0.02
7 480 470 6.8 6.79 ‐0.01
8 370 580 7.0 6.98 ‐0.02
9 270 680 7.2 7.18 ‐0.02
10 180 770 7.4 7.41 0.01
11 120 830 7.6 7.62 0.02
12 80 870 7.8 7.86 0.06
13 50 900 8.0 8.05 0.05
14 0 950 (Neat Base) 9.14 NA
4.00 3.90 ‐0.10
7.01 7.02 0.01
10.04 10.00 ‐0.04
pH 4 Reference Buffer @ 21°C
pH 7 Reference Buffer @ 21°C
pH 10 Reference Buffer @ 21°C
Example: Buffer Prep and pH
Selected data for phosphate buffer prep compared with
literature target pH’s
Sample A (μl) B (μl) Target pH CM3 pH           Glass pH         Δ
1 950 0 (Neat Acid) 4.47 4.50 0.03
2 870 80 5.8 5.80 5.79 ‐0.01
3 840 110 6.0 5.94 5.95 0.01
4 810 140 6.2 6.03 6.06 0.03
5 700 250 6.4 6.31 6.38 0.07
6 600 350 6.6 6.58 6.59 0.01
7 480 470 6.8 6.79 6.81 0.02
8 370 580 7.0 6.98 7.00 0.02
9 270 680 7.2 7.18 7.21 0.03
10 180 770 7.4 7.41 7.44 0.03
11 120 830 7.6 7.62 7.65 0.03
12 80 870 7.8 7.86 7.85 ‐0.01
13 50 900 8.0 8.05 8.07 0.02
14 0 950 (Neat Base) 9.14 9.13 ‐0.01
4.00 3.90 4.03 0.13
7.01 7.02 7.03 0.01
10.04 10.00 10.05 0.05
pH 4 Reference Buffer @ 21°C
pH 7 Reference Buffer @ 21°C
pH 10 Reference Buffer @ 21°C
Example: Buffer Prep and pH
Selected data for phosphate buffer prep compared with
glass electrode
Example: Buffer Prep and pH
Histidine.HCl/Histidine Citric Acid/Trisodium Citrate
Other Examples:
Conclusions
• Need to optimize or verify liquid handling, pH or
viscosity? Let the robot do the work!
• Buffer prep is a breeze with precise liquid handling
and rapid pH measurement
• Increased buffer prep throughput creates need for
automated buffer exchange
Acknowledgements:
• KBI Biopharma, Inc. for the vision to invest in
automation
• Freeslate/Unchained Labs for great engineering and
great support

More Related Content

PDF
High-throughput and Automated Process Development for Accelerated Biotherapeu...
PDF
Platforms for mAb Commercialization
PDF
Getting Biopharmaceutical Production Processes Right the First Time
PDF
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
PDF
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
PDF
Highly accelerated platforms for mAb and next generation mAb manufacturing
PDF
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
PDF
Covering a Spectrum of New Product Development Technologies - From Cells to C...
High-throughput and Automated Process Development for Accelerated Biotherapeu...
Platforms for mAb Commercialization
Getting Biopharmaceutical Production Processes Right the First Time
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Highly accelerated platforms for mAb and next generation mAb manufacturing
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Covering a Spectrum of New Product Development Technologies - From Cells to C...

What's hot (20)

PDF
From Screening to QC: Development Considerations for Octet Methods
PDF
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
PDF
Employing ForteBio Octet platform for the development of a dual-binding poten...
PDF
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
PPTX
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
PDF
Orphan Biopharmaceuticals & the CDMO
PDF
Fine-tuning your purification process: Using mechanistic modeling of chromato...
PDF
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
DOCX
Evolution of mAb Downstream Platforms
PDF
Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...
PDF
Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...
PDF
A Platform Approach to Preformulation Development for Antibody Products
PDF
Analytical methods for therapeutic antibody characterization, comparability, ...
PDF
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
PDF
Next Generation Recombinant Protein Manufacturing
PDF
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
PDF
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
PDF
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
PDF
Octet Potency Assay: Development, Qualification and Validation Strategies
PDF
Integrated utilization of high-throughput bioreactors & high-throughput analy...
From Screening to QC: Development Considerations for Octet Methods
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Employing ForteBio Octet platform for the development of a dual-binding poten...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Orphan Biopharmaceuticals & the CDMO
Fine-tuning your purification process: Using mechanistic modeling of chromato...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Evolution of mAb Downstream Platforms
Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...
Up to Speed: Cell Culture Development. European Biopharmaceutical Review July...
A Platform Approach to Preformulation Development for Antibody Products
Analytical methods for therapeutic antibody characterization, comparability, ...
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Next Generation Recombinant Protein Manufacturing
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Octet Potency Assay: Development, Qualification and Validation Strategies
Integrated utilization of high-throughput bioreactors & high-throughput analy...
Ad

Viewers also liked (15)

PDF
KBI Case Studies: Process Development
PDF
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
PDF
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
PDF
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
PDF
Managing Raw Material Variability Over the Life-cycle of a Molecule
PDF
Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...
PDF
A Comparison of Protein A Chromatographic Stationary Phases
PDF
A Comparison of Multimodal Chromatographic Resin: Protein Binding & Selectivity
PDF
Importance of Understanding the Physical State of Excipients in a Freeze Drie...
PPTX
A Comparison of Multimodal Chromatography Resin: Case Study
PDF
Quality by Design at a Biopharma CMO (Contract Manufacturing Organization)
PDF
High Throughput PEGylation Process Development – Screening & Optimization Stu...
PDF
Accelerated Stability During Formulation Development of Early Stage Protein T...
PDF
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
PDF
A Manufacturer’s Perspective on Innovations in Biomanufacturing
KBI Case Studies: Process Development
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
Managing Raw Material Variability Over the Life-cycle of a Molecule
Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...
A Comparison of Protein A Chromatographic Stationary Phases
A Comparison of Multimodal Chromatographic Resin: Protein Binding & Selectivity
Importance of Understanding the Physical State of Excipients in a Freeze Drie...
A Comparison of Multimodal Chromatography Resin: Case Study
Quality by Design at a Biopharma CMO (Contract Manufacturing Organization)
High Throughput PEGylation Process Development – Screening & Optimization Stu...
Accelerated Stability During Formulation Development of Early Stage Protein T...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
A Manufacturer’s Perspective on Innovations in Biomanufacturing
Ad

Similar to Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing (20)

PDF
Chromatography: Trends and Developments in MAb Screening and Characterization
PDF
Zinsser Analytic Info & News 2018
PPTX
Generic product development and technology transfer : At a glance
PPTX
Comparative Study of Conventional and Advanced Instruments and Equipment used...
PDF
ToothpasteRheology_SOR_Ozkan etal 2014v1
PDF
Automated sample preparation using the GERSTEL MPS Series and MAESTRO softwar...
PDF
2018 StatLab catalog
PDF
Oxidation of a Glycosylated Therapeutic Protein
PPSX
IUCell001_Basic Handling_A.ppsx
PDF
Accurex Product Guide.pdf
PPT
DOE Applications in Process Chemistry Presentation
PDF
Lab Unlimited Labortops Promotions 2016 Q4
DOCX
Scale up of liquid orals
PDF
AppNote_MFI Manual Viscosity Study
PPTX
Parenteral Preformulation Final 070220.pptx
PPTX
AMIT - QbD, a case study
PPTX
LABORATORY PROCEDURES & ASSESSMENT IN FOOD INDUSTRY.pptx
PPTX
Process validation- This guidance incorporates principles and approaches that...
PPTX
sawsan-mohamed-amer-cairo-university-egypt.pptx
Chromatography: Trends and Developments in MAb Screening and Characterization
Zinsser Analytic Info & News 2018
Generic product development and technology transfer : At a glance
Comparative Study of Conventional and Advanced Instruments and Equipment used...
ToothpasteRheology_SOR_Ozkan etal 2014v1
Automated sample preparation using the GERSTEL MPS Series and MAESTRO softwar...
2018 StatLab catalog
Oxidation of a Glycosylated Therapeutic Protein
IUCell001_Basic Handling_A.ppsx
Accurex Product Guide.pdf
DOE Applications in Process Chemistry Presentation
Lab Unlimited Labortops Promotions 2016 Q4
Scale up of liquid orals
AppNote_MFI Manual Viscosity Study
Parenteral Preformulation Final 070220.pptx
AMIT - QbD, a case study
LABORATORY PROCEDURES & ASSESSMENT IN FOOD INDUSTRY.pptx
Process validation- This guidance incorporates principles and approaches that...
sawsan-mohamed-amer-cairo-university-egypt.pptx

More from KBI Biopharma (19)

PDF
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
PDF
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
PDF
Application and Adaptation of Platform and Alternative Purification Steps to ...
PDF
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
PDF
Calorimetry study of a mAb that precipitates upon thermal denaturation
PDF
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
PDF
Effects of Additives on Reversibility of Thermal Unfolding
PDF
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
PDF
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
PDF
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
PDF
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
PDF
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
PDF
Characterizing the aggregation and conformation of protein therapeutics
PDF
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
PDF
Some Unusual Aggregation Phenomena in Recombinant Proteins
PDF
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
PDF
Is Any Measurement Method Optimal for All Aggregate Sizes and Types?
PDF
Focus on aggregation: types, causes, characterization, and impact
PDF
Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Application and Adaptation of Platform and Alternative Purification Steps to ...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Calorimetry study of a mAb that precipitates upon thermal denaturation
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Effects of Additives on Reversibility of Thermal Unfolding
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Characterizing the aggregation and conformation of protein therapeutics
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Some Unusual Aggregation Phenomena in Recombinant Proteins
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
Is Any Measurement Method Optimal for All Aggregate Sizes and Types?
Focus on aggregation: types, causes, characterization, and impact
Sensitivity and Reproducibility of Protein Aggregate Analysis by Sedimentatio...

Recently uploaded (20)

PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
antibiotics rational use of antibiotics.pptx
PPTX
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
PPTX
1. Basic chemist of Biomolecule (1).pptx
PPTX
Reading between the Rings: Imaging in Brain Infections
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
Cardiovascular - antihypertensive medical backgrounds
PDF
Transcultural that can help you someday.
PPTX
the psycho-oncology for psychiatrists pptx
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
Clinical approach and Radiotherapy principles.pptx
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
Acid Base Disorders educational power point.pptx
PPTX
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
PDF
Cardiology Pearls for Primary Care Providers
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPTX
regulatory aspects for Bulk manufacturing
PPT
Obstructive sleep apnea in orthodontics treatment
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
MENTAL HEALTH - NOTES.ppt for nursing students
antibiotics rational use of antibiotics.pptx
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
1. Basic chemist of Biomolecule (1).pptx
Reading between the Rings: Imaging in Brain Infections
Electrolyte Disturbance in Paediatric - Nitthi.pptx
Cardiovascular - antihypertensive medical backgrounds
Transcultural that can help you someday.
the psycho-oncology for psychiatrists pptx
surgery guide for USMLE step 2-part 1.pptx
Clinical approach and Radiotherapy principles.pptx
neurology Member of Royal College of Physicians (MRCP).ppt
Acid Base Disorders educational power point.pptx
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
Cardiology Pearls for Primary Care Providers
Acute Coronary Syndrome for Cardiology Conference
regulatory aspects for Bulk manufacturing
Obstructive sleep apnea in orthodontics treatment
PEADIATRICS NOTES.docx lecture notes for medical students

Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing

  • 1. Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing The KBI Experience Daniel Kinder 23.MARCH.2016
  • 2. a customer and science-focused contract development & manufacturing organization
  • 3. Boulder, Colorado - Microbial Process Development - Microbial cGMP Manufacturing - Analytical Development Durham, North Carolina - Cell Line Development - Cell Culture cGMP Manufacturing - Microbial cGMP Manufacturing - Analytical QC, Formulation, Stability RTP, North Carolina - Cell Culture Process Development - Microbial Process Development - Analytical Development Our Locations
  • 4. Our Services Cell Line Development Upstream Process Development API Manufacturing Downstream Process Development Analytical & Formulation
  • 5. Preformulation Services Biophysical Screening Scout the various biophysical techniques (DSC, DLS, FTIR, CD) to determine which are most informative about the protein’s thermal and conformational properties Effect of pH, buffer type, and excipients on thermal and conformational stability Solubility Studies Effect of pH, buffer type, ionic strength, excipients Surfactant Screening Studies Effect of surfactant type and concentration on aggregate and particle formation DOE Accelerated Stability Studies Effect of pH, buffer type, ionic strength, and excipients on chemical stability utilizing statistical design of experiments (DOE) Forced Degradation Studies Oxidation, acid & base hydrolysis, deamidation, heat, agitation, light, freeze/thaw
  • 6. Automation Opportunities • Meet the increasing demand for more drug candidates with faster formulation and assessment • Conduct larger DOE’s earlier to reduce the risk of late stage formulation failures • High throughput experimental design and data management to accelerate decision making Automated sample preparation, processing and analysis Electronic experimental design and data management
  • 10. Freeslate CM3 Biologics Formulation Development Workstation
  • 12. CM3 Workstation Devices 6-Channel Pipette • Air-displacement disposable tips • Variable pitch for access to a range of vial sizes • Multiple tip sizes enable 10-1000μL pipetting with ~1% cv precision Positive Displacement Pipette • Precise liquid handling ideal for even viscous samples • Tip sizes enable 10μL- 10mL pipetting 4-Channel Solid State pH Meter • 4-channel or single channel mode • 96 samples can be read in 30 minutes with ±0.1 pH accuracy • The 3mm probes can easily access 96 well plates
  • 13. CM3 Workstation Devices Vial/plate Moving • Vial/Plate Gripper moves vials, microtiter plates and pipette tip racks • Robotic hand performs capping/uncapping and removes plate covers Storage Carousel • Carousel hotel provides storage for up to 32 racks/plates • Barcode enabled Viscosity Measurement • Measurement requires only 100μL • Shear rate measurement to evaluate Newtonian fluid behavior • Temperature control 4-40ºC
  • 14. CM3 Workstation Devices Appearance Testing with Image Station • 2, 4, 5, 10 and 20mL vials • Quantitative color matching to Eur. Pharm. BY1-BY7 standards • Calibrated turbidity measurement 10- 1000 NTU • Particle Counting with digital image analysis detects sizes from 80μm
  • 15. CM3 On-Board Analysis pH Color Analysis Viscosity Particle Count Turbidityuv/vis
  • 16. CM3 Integrated Analysis Formulation Experiment Master Plate Uv/vis Plate DLS Plate Chromatography Plates (SEC, CEX, RP, etc.) IEF Plate CGE Plate
  • 17. CM3 Software Suite: Library Studio® • Design complex experiments with realistic graphic display and text recipes • Assign sample group names and sample ID barcodes • Automatically design volume gradients, scale calculations, mathematical functions and more
  • 18. CM3 Software Suite: Automation Studio® • Executes experimental workflows • Controls all integrated analytical instruments • Allows direct control over the CM3 devices
  • 19. CM3 Software Suite: Automation Studio® • Quick review of data from individual experiments by query of date, data type, library ID, experiment conditions, etc.
  • 20. CM3 Software Suite: PolyView® • View all data from each experimental condition in one organized spreadsheet • Graphical data and images displayed as spreadsheet • Query data from multiple experiments for trend analysis and reporting * Images from www.Freeslate.com * *
  • 21. Questions asked by colleagues: • What does it do? • How fast? • How many? • How reliable is the data? How do you know? • How do I get my data? • How much effort to use?
  • 22. CM3 Analytical Verification • Liquid Handling (LiHa) Verification • Volumes confirmed by calibrated devices • Specific to current application • pH Verification • Daily calibration/verification • Comparison with calibrated glass electrode • Tip-to-tip variance • Time-dependent drift • Viscometer verification • Calibration with standards • Protein or glycerol routine injections
  • 23. LiHa precision/accuracy affected by: • Tip size (be sure to use the right one) • Syringe size (max motor/drive length) • Dispense categories (LiHa parameters) • Touch-off • Aspirate/dispense heights, speeds • Delays, air gaps, etc. • Nature of sample (e.g. viscosity, surface tension) • Nature of vessels (source and target) • Order of addition (what’s already in the target vial)
  • 24. LiHa Event Sequence Computer Digital Controller Voltage MotorGearSyringe Valve 6’ of Tubing Pipet Tip Sample System Fluid
  • 25. LiHa Verification - Methods • Gravimetric • Slow but sure • Use good technique, correct density for temperature • Automated weighing a plus • Unlimited volume range • Colorimetric • Uv/vis or fluorescent dyes (Orange-G, Me-Orange, Eosin-Y) • Must calibrate with a verified pipet • Very rapid read (96-wells in 10 seconds) • Limited to volume of uv/vis plate (~200μL)
  • 26. Example LiHa Optimization (6-Tip, Gravimetric) 1000µL ADT Target (μL) Actual (μL) %CV %∆ 225 225.6 ± 0.8 0.4 0.3 450 451.1 ± 2.0 0.44 0.2 675 677.4 ± 1.1 0.16 0.4 900 902.6 ± 3.5 0.39 0.3
  • 27. Colorimetric LiHa Optimization STEP 1: Set dispense parameters to a null value Set these values to null (Slope = 1, Intercept = 0)
  • 28. Colorimetric LiHa Optimization STEP 2: Dispense stock dye solution into uv/vis plate Library Studio® Design SpectraMax® O.D. data Manually pipet this row
  • 29. Example LiHa Optimization STEP 3: Determine abs-to-volume conversion function Beer’s Law plot for 200μL ADT Intercept -3.137 Slope 184.06 RSQ 1.0000 Standard Function Target volume (μL) Average (AU) SD 45.0 0.26 0.01 90.0 0.51 0.00 135.0 0.75 0.00 180.0 1.00 0.00 Standard curve
  • 30. Example LiHa Optimization “Null” Values 200µL ADT Target (μL) Actual (μL) %CV %∆ 45 44.1 ± 0.4 0.9 2 90 87.6 ± 0.4 0.4 3 135 131.6 ± 0.7 0.5 3 180 175.4 ± 0.6 0.3 3
  • 31. Example LiHa Optimization STEP 4: Plot resulting volumes to derive LiHa curve Optimization curve for 200μL ADT Intercept -0.191 Slope 1.0273 LiHa Function
  • 32. Colorimetric LiHa Optimization STEP 5: Input optimized values for dispense category Plug in Slope and Intercept
  • 33. Example LiHa Optimization Corrected Values 200µL ADT Target (μL) Actual (μL) %CV %∆ 45 44.6 ± 0.2 0.4 0.9 90 89.6 ± 0.3 0.3 0.4 135 135.0 ± 0.5 0.4 0.0 180 180.4 ± 0.9 0.5 0.2
  • 34. Example LiHa Optimization Target Actual %CV %∆ Target Actual %CV %∆ Target Actual %CV %Δ 11 10.5 2 5% 45 44.6 0.50 1% 225 225.6 0.4 0% 22 21.6 1 2% 90 89.6 0.40 0% 450 451.1 0.5 0% 33 32.9 0.8 0% 135 135.0 0.40 0% 675 677.4 0.2 0% 45 44.8 0.8 0% 180 180.4 0.50 0% 900 902.6 0.4 0% Target Actual %CV %Δ Target Actual %CV %Δ Target Actual %CV %Δ 11 11.4 2.1 4% 22 22.1 1.9 0% 50 50.1 0.6 0% 22 21.9 2.5 0% 45 45.0 1.0 0% 100 101.4 0.3 1% 34 34.1 0.6 0% 70 70.6 0.9 1% 150 151.4 0.5 1% 45 44.6 0.5 1% 90 90.9 0.4 1% 200 199.9 0.2 0% Target Actual %CV %Δ Target Actual %CV %Δ Target Actual %CV %Δ 225 224.5 0.3 0% 1100 1117.5 2.9 2% 2250 2215.2 0.9 2% 450 449.9 0.2 0% 2200 2230.3 1.0 1% 4500 4474.7 0.2 1% 675 673.7 0.1 0% 3300 3274.4 0.3 1% 6750 6727.9 0.3 0% 900 898.4 0.0 0% 4400 4342.2 0.3 1% 9000 9003.0 0.0 0% 1mL PDT 5mL PDT 10mL PDT 50µL ADT 200µL ADT 1000µL ADT 50µL PDT 100µL PDT 250µL PDT
  • 35. What about viscous samples? Pipet neat glycerol to prepare mixtures and measure viscosity: %wt Glycerol Viscosity (CM3) 0.0% 0.82 18.8% 1.51 40.3% 3.52 50.5% 5.69 60.1% 9.66 64.4% 13.14 67.0% 15.83 69.8% 19.55 71.9% 23.34 74.8% 29.71 76.7% 35.79 79.8% 47.14 ( Viscosity of glycerol = 1412 cP ! )
  • 36. Literature Resources • “A Simple Method for Validation and Verification of Pipettes Mounted on Automated Liquid Handlers”, Michael Stangegaard et al, Journal of Laboratory Automation, October, 2011, pp 381- 386. • “Practical Considerations of Liquid Handling Devices in Drug Discovery”, Sergio C. Chai et al, (online book) http://dx.doi.org/10.5772/52546. • “Improving Accuracy by Use of Technique Calibration”, Lisa Knapp, et al, (Beckman Coulter technical bulletin) https://www.beckmancoulter.com/wsrportal/bibliography?docnam e=T-1915A.pdf.
  • 37. Example: Buffer Prep and pH • Biologic pharmaceuticals are typically handled in formulations of very precise composition • pH control is maintained by buffer systems (phosphate, citrate, acetate, etc.) • An in-house table of buffer recipes to achieve target pH’s would be useful • Great CM3 training/verification activity
  • 38. Example: Buffer Prep and pH Library Studio® Design of Buffer Prep
  • 39. Example: Buffer Prep and pH Mixtures from buffer stock solutions Buffer Acid Buffer Base Target pH CM3 preparing citrate buffer mixtures in 96-DWP
  • 40. Example: Buffer Prep and pH Plot of pH vs. Phosphate Base added ( NaH2PO4/Na2HPO4 )
  • 41. Sample A (μl) B (μl) Target pH CM3 pH           Δ 1 950 0 (Neat Acid) 4.47 NA 2 870 80 5.8 5.80 0.00 3 840 110 6.0 5.94 ‐0.06 4 810 140 6.2 6.03 ‐0.17 5 700 250 6.4 6.31 ‐0.09 6 600 350 6.6 6.58 ‐0.02 7 480 470 6.8 6.79 ‐0.01 8 370 580 7.0 6.98 ‐0.02 9 270 680 7.2 7.18 ‐0.02 10 180 770 7.4 7.41 0.01 11 120 830 7.6 7.62 0.02 12 80 870 7.8 7.86 0.06 13 50 900 8.0 8.05 0.05 14 0 950 (Neat Base) 9.14 NA 4.00 3.90 ‐0.10 7.01 7.02 0.01 10.04 10.00 ‐0.04 pH 4 Reference Buffer @ 21°C pH 7 Reference Buffer @ 21°C pH 10 Reference Buffer @ 21°C Example: Buffer Prep and pH Selected data for phosphate buffer prep compared with literature target pH’s
  • 42. Sample A (μl) B (μl) Target pH CM3 pH           Glass pH         Δ 1 950 0 (Neat Acid) 4.47 4.50 0.03 2 870 80 5.8 5.80 5.79 ‐0.01 3 840 110 6.0 5.94 5.95 0.01 4 810 140 6.2 6.03 6.06 0.03 5 700 250 6.4 6.31 6.38 0.07 6 600 350 6.6 6.58 6.59 0.01 7 480 470 6.8 6.79 6.81 0.02 8 370 580 7.0 6.98 7.00 0.02 9 270 680 7.2 7.18 7.21 0.03 10 180 770 7.4 7.41 7.44 0.03 11 120 830 7.6 7.62 7.65 0.03 12 80 870 7.8 7.86 7.85 ‐0.01 13 50 900 8.0 8.05 8.07 0.02 14 0 950 (Neat Base) 9.14 9.13 ‐0.01 4.00 3.90 4.03 0.13 7.01 7.02 7.03 0.01 10.04 10.00 10.05 0.05 pH 4 Reference Buffer @ 21°C pH 7 Reference Buffer @ 21°C pH 10 Reference Buffer @ 21°C Example: Buffer Prep and pH Selected data for phosphate buffer prep compared with glass electrode
  • 43. Example: Buffer Prep and pH Histidine.HCl/Histidine Citric Acid/Trisodium Citrate Other Examples:
  • 44. Conclusions • Need to optimize or verify liquid handling, pH or viscosity? Let the robot do the work! • Buffer prep is a breeze with precise liquid handling and rapid pH measurement • Increased buffer prep throughput creates need for automated buffer exchange
  • 45. Acknowledgements: • KBI Biopharma, Inc. for the vision to invest in automation • Freeslate/Unchained Labs for great engineering and great support